Related Experiment Video
Updated: Jan 9, 2026

Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
Interplay between lipid metabolism and macrophage dynamics in ischemic stroke: From mechanistic insights to
Jiagui Huang1, Heng Yang1, Li Zhong1
1Department of Neurology, The Second People's Hospital of Yibin, Yibin, Sichuan, China.
Abstract:
Ischemic stroke (IS), a leading global cause of long-term disability, is treated with therapies (e.g., thrombolysis, mechanical thrombectomy) constrained by a narrow therapeutic window and ischemia-reperfusion injury risks. Neuroinflammation-exhibiting dual, time-dependent (protective vs. harmful) effects-complicates static targeting. Macrophages, encompassing resident microglia and infiltrating blood-derived macrophages, regulate neuroinflammation via marked heterogeneity and metabolic reprogramming in the dynamic IS microenvironment. Herein, we review metabolic reprogramming in the IS milieu, lipid metabolism in IS-associated macrophages, its functional consequences, therapeutic targets, and emerging approaches. Additionally, we address current challenges and future directions, and highlight translational perspectives in IS. In summary, macrophages emerge as metabolic hubs in IS, with lipid metabolism as a critical targetable axis for improving stroke therapy.
More Related Videos
Related Concept Videos
Inflammation
Atherosclerosis III: Management
Atherosclerosis I: Introduction
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Coronary Artery Disease II: Pathophysiology

